Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Defilade Capital Management, L.P. (CIK 2088557) reported $746.9M across 39 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: LLY ($46.9M, 6.28%), PFE ($42.7M, 5.71%), VEEV ($42.0M, 5.62%), BMRN ($39.0M, 5.22%), PTCT ($35.4M, 4.74%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | $46.9M | 6.28% | 39,086 | Added |
| 2 | PFE | PFIZER INC | $42.7M | 5.71% | 1.8M | Added |
| 3 | VEEV | VEEVA SYS INC | $42.0M | 5.62% | 236,709 | New |
| 4 | BMRN | BIOMARIN PHARMACEUTICAL INC | $39.0M | 5.22% | 682,005 | New |
| 5 | PTCT | PTC THERAPEUTICS INC | $35.4M | 4.74% | 433,699 | Added |
| 6 | BAX | BAXTER INTL INC | $31.1M | 4.17% | 1.5M | New |
| 7 | INSM | INSMED INC | $30.0M | 4.02% | 281,838 | Added |
| 8 | ZBH | ZIMMER BIOMET HOLDINGS INC | $27.3M | 3.66% | 317,426 | Trimmed |
| 9 | PODD | INSULET CORP | $26.9M | 3.61% | 176,932 | New |
| 10 | TMO | THERMO FISHER SCIENTIFIC INC | $26.0M | 3.49% | 51,934 | New |
| 11 | ABT | ABBOTT LABORATORIES | $25.9M | 3.47% | 285,778 | New |
| 12 | ASND | ASCENDIS PHARMA A/S | $25.3M | 3.39% | 94,843 | New |
| 13 | SOLV | SOLVENTUM CORP | $24.4M | 3.27% | 316,454 | New |
| 14 | MDT | MEDTRONIC PLC | $23.7M | 3.18% | 303,301 | New |
| 15 | ELAN | ELANCO ANIMAL HEALTH INC | $21.3M | 2.85% | 864,080 | Trimmed |
| 16 | AGIO | AGIOS PHARMACEUTICALS INC | $20.3M | 2.72% | 546,848 | New |
| 17 | NVST | ENVISTA HOLDINGS CORPORATION | $19.1M | 2.56% | 726,108 | New |
| 18 | RVMD | REVOLUTION MEDICINES INC | $15.5M | 2.08% | 82,827 | Trimmed |
| 19 | ICUI | ICU MED INC | $15.5M | 2.07% | 105,700 | Trimmed |
| 20 | COGT | COGENT BIOSCIENCES INC | $15.2M | 2.04% | 393,441 | Added |
| 21 | LNTH | LANTHEUS HLDGS INC | $14.7M | 1.97% | 132,662 | Trimmed |
| 22 | OCUL | OCULAR THERAPEUTIX INC | $14.6M | 1.96% | 1.5M | Added |
| 23 | ELDN | ELEDON PHARMACEUTICALS INC | $13.9M | 1.86% | 3.5M | Trimmed |
| 24 | TYRA | TYRA BIOSCIENCES INC | $12.0M | 1.61% | 376,870 | New |
| 25 | OLMA | OLEMA PHARMACEUTICALS INC | $11.6M | 1.55% | 924,758 | Trimmed |
Source: SEC Form 13F filings · as of 2026-06-30